Evaluating New Ophthalmic Digital Devices for Safety and Effectiveness in the Context of Rapid Technological Development

Zachary M. Bodnar, Ronald Schuchard, David Myung, Michelle E. Tarver, Mark S. Blumenkranz, Natalie A. Afshari, Mark S. Humayun, Christie Morse, Ken Nischal, Michael X Repka, Derek Sprunger, Michael Trese, Malvina B. Eydelman

Research output: Contribution to journalArticle

Abstract

Importance: The US Food and Drug Administration's medical device regulatory pathway was initially conceived with hardware devices in mind. The emerging market for ophthalmic digital devices necessitates an evolution of this paradigm. Objectives: To facilitate innovation in ophthalmic digital health with attention to safety and effectiveness. Evidence Review: This article presents a summary of the presentations, discussions, and literature review that occurred during a joint Ophthalmic Digital Health workshop of the American Academy of Ophthalmology, the American Academy of Pediatrics, the American Association for Pediatric Ophthalmology and Strabismus, the American Society of Cataract and Refractive Surgery, the American Society of Retina Specialists, the Byers Eye Institute at Stanford and the US Food and Drug Administration. Findings: Criterion standards and expert graders are critically important in the evaluation of automated systems and telemedicine platforms. Training at all levels is important for the safe and effective operation of digital health devices. The risks associated with automation are substantially increased in rapidly progressive diseases. Cybersecurity and patient privacy warrant meticulous attention. Conclusions and Relevance: With appropriate attention to safety and effectiveness, digital health technology could improve screening and treatment of ophthalmic diseases and improve access to care..

Original languageEnglish (US)
JournalJAMA ophthalmology
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Equipment Safety
Equipment and Supplies
United States Food and Drug Administration
Health
Computer Security
Refractive Surgical Procedures
Safety
Biomedical Technology
Eye Diseases
Telemedicine
Privacy
Automation
Cataract
Retina
Joints
Pediatrics
Education

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Bodnar, Z. M., Schuchard, R., Myung, D., Tarver, M. E., Blumenkranz, M. S., Afshari, N. A., ... Eydelman, M. B. (2019). Evaluating New Ophthalmic Digital Devices for Safety and Effectiveness in the Context of Rapid Technological Development. JAMA ophthalmology. https://doi.org/10.1001/jamaophthalmol.2019.1576

Evaluating New Ophthalmic Digital Devices for Safety and Effectiveness in the Context of Rapid Technological Development. / Bodnar, Zachary M.; Schuchard, Ronald; Myung, David; Tarver, Michelle E.; Blumenkranz, Mark S.; Afshari, Natalie A.; Humayun, Mark S.; Morse, Christie; Nischal, Ken; Repka, Michael X; Sprunger, Derek; Trese, Michael; Eydelman, Malvina B.

In: JAMA ophthalmology, 01.01.2019.

Research output: Contribution to journalArticle

Bodnar, ZM, Schuchard, R, Myung, D, Tarver, ME, Blumenkranz, MS, Afshari, NA, Humayun, MS, Morse, C, Nischal, K, Repka, MX, Sprunger, D, Trese, M & Eydelman, MB 2019, 'Evaluating New Ophthalmic Digital Devices for Safety and Effectiveness in the Context of Rapid Technological Development', JAMA ophthalmology. https://doi.org/10.1001/jamaophthalmol.2019.1576
Bodnar, Zachary M. ; Schuchard, Ronald ; Myung, David ; Tarver, Michelle E. ; Blumenkranz, Mark S. ; Afshari, Natalie A. ; Humayun, Mark S. ; Morse, Christie ; Nischal, Ken ; Repka, Michael X ; Sprunger, Derek ; Trese, Michael ; Eydelman, Malvina B. / Evaluating New Ophthalmic Digital Devices for Safety and Effectiveness in the Context of Rapid Technological Development. In: JAMA ophthalmology. 2019.
@article{f4d8047e6ea54728a0503bdcbf9772cb,
title = "Evaluating New Ophthalmic Digital Devices for Safety and Effectiveness in the Context of Rapid Technological Development",
abstract = "Importance: The US Food and Drug Administration's medical device regulatory pathway was initially conceived with hardware devices in mind. The emerging market for ophthalmic digital devices necessitates an evolution of this paradigm. Objectives: To facilitate innovation in ophthalmic digital health with attention to safety and effectiveness. Evidence Review: This article presents a summary of the presentations, discussions, and literature review that occurred during a joint Ophthalmic Digital Health workshop of the American Academy of Ophthalmology, the American Academy of Pediatrics, the American Association for Pediatric Ophthalmology and Strabismus, the American Society of Cataract and Refractive Surgery, the American Society of Retina Specialists, the Byers Eye Institute at Stanford and the US Food and Drug Administration. Findings: Criterion standards and expert graders are critically important in the evaluation of automated systems and telemedicine platforms. Training at all levels is important for the safe and effective operation of digital health devices. The risks associated with automation are substantially increased in rapidly progressive diseases. Cybersecurity and patient privacy warrant meticulous attention. Conclusions and Relevance: With appropriate attention to safety and effectiveness, digital health technology could improve screening and treatment of ophthalmic diseases and improve access to care..",
author = "Bodnar, {Zachary M.} and Ronald Schuchard and David Myung and Tarver, {Michelle E.} and Blumenkranz, {Mark S.} and Afshari, {Natalie A.} and Humayun, {Mark S.} and Christie Morse and Ken Nischal and Repka, {Michael X} and Derek Sprunger and Michael Trese and Eydelman, {Malvina B.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1001/jamaophthalmol.2019.1576",
language = "English (US)",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",

}

TY - JOUR

T1 - Evaluating New Ophthalmic Digital Devices for Safety and Effectiveness in the Context of Rapid Technological Development

AU - Bodnar, Zachary M.

AU - Schuchard, Ronald

AU - Myung, David

AU - Tarver, Michelle E.

AU - Blumenkranz, Mark S.

AU - Afshari, Natalie A.

AU - Humayun, Mark S.

AU - Morse, Christie

AU - Nischal, Ken

AU - Repka, Michael X

AU - Sprunger, Derek

AU - Trese, Michael

AU - Eydelman, Malvina B.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Importance: The US Food and Drug Administration's medical device regulatory pathway was initially conceived with hardware devices in mind. The emerging market for ophthalmic digital devices necessitates an evolution of this paradigm. Objectives: To facilitate innovation in ophthalmic digital health with attention to safety and effectiveness. Evidence Review: This article presents a summary of the presentations, discussions, and literature review that occurred during a joint Ophthalmic Digital Health workshop of the American Academy of Ophthalmology, the American Academy of Pediatrics, the American Association for Pediatric Ophthalmology and Strabismus, the American Society of Cataract and Refractive Surgery, the American Society of Retina Specialists, the Byers Eye Institute at Stanford and the US Food and Drug Administration. Findings: Criterion standards and expert graders are critically important in the evaluation of automated systems and telemedicine platforms. Training at all levels is important for the safe and effective operation of digital health devices. The risks associated with automation are substantially increased in rapidly progressive diseases. Cybersecurity and patient privacy warrant meticulous attention. Conclusions and Relevance: With appropriate attention to safety and effectiveness, digital health technology could improve screening and treatment of ophthalmic diseases and improve access to care..

AB - Importance: The US Food and Drug Administration's medical device regulatory pathway was initially conceived with hardware devices in mind. The emerging market for ophthalmic digital devices necessitates an evolution of this paradigm. Objectives: To facilitate innovation in ophthalmic digital health with attention to safety and effectiveness. Evidence Review: This article presents a summary of the presentations, discussions, and literature review that occurred during a joint Ophthalmic Digital Health workshop of the American Academy of Ophthalmology, the American Academy of Pediatrics, the American Association for Pediatric Ophthalmology and Strabismus, the American Society of Cataract and Refractive Surgery, the American Society of Retina Specialists, the Byers Eye Institute at Stanford and the US Food and Drug Administration. Findings: Criterion standards and expert graders are critically important in the evaluation of automated systems and telemedicine platforms. Training at all levels is important for the safe and effective operation of digital health devices. The risks associated with automation are substantially increased in rapidly progressive diseases. Cybersecurity and patient privacy warrant meticulous attention. Conclusions and Relevance: With appropriate attention to safety and effectiveness, digital health technology could improve screening and treatment of ophthalmic diseases and improve access to care..

UR - http://www.scopus.com/inward/record.url?scp=85066829132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066829132&partnerID=8YFLogxK

U2 - 10.1001/jamaophthalmol.2019.1576

DO - 10.1001/jamaophthalmol.2019.1576

M3 - Article

C2 - 31169870

AN - SCOPUS:85066829132

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

ER -